MUC5AC and lung cancer: High-throughput sequencing of 141 lung cancer patient samples revealed a significant inverse correlation between circRABL2B and MUC5AC expression, with patients exhibiting low circRABL2B and high MUC5AC levels showing the worst survival outcomes (HR = 2.00; 95% CI = 1.12–3.57).